Published in Malar J on September 22, 2013
Systematic review of sub-microscopic P. vivax infections: prevalence and determining factors. PLoS Negl Trop Dis (2015) 1.19
Plasmodium prevalence and artemisinin-resistant falciparum malaria in Preah Vihear Province, Cambodia: a cross-sectional population-based study. Malar J (2014) 1.07
Hotspots of Malaria Transmission in the Peruvian Amazon: Rapid Assessment through a Parasitological and Serological Survey. PLoS One (2015) 0.98
A systematic review of sub-microscopic Plasmodium vivax infection. Malar J (2015) 0.87
Epidemiology of Plasmodium vivax Malaria in Peru. Am J Trop Med Hyg (2016) 0.84
Plasmodium vivax malaria at households: spatial clustering and risk factors in a low endemicity urban area of the northwestern Peruvian coast. Malar J (2015) 0.83
Sero-epidemiological evaluation of Plasmodium falciparum malaria in Senegal. Malar J (2015) 0.80
Heterogeneous malaria transmission in long-term Afghan refugee populations: a cross-sectional study in five refugee camps in northern Pakistan. Malar J (2016) 0.78
Is there malaria transmission in urban settings in Colombia? Malar J (2015) 0.75
Serology reveals heterogeneity of Plasmodium falciparum transmission in northeastern South Africa: implications for malaria elimination. Malar J (2017) 0.75
Household level spatio-temporal analysis of Plasmodium falciparum and Plasmodium vivax malaria in Ethiopia. Parasit Vectors (2017) 0.75
Spatio-temporal analysis of malaria incidence in the Peruvian Amazon Region between 2002 and 2013. Sci Rep (2017) 0.75
Malaria epidemiology in low-endemicity areas of the northern coast of Ecuador: high prevalence of asymptomatic infections. Malar J (2017) 0.75
Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg (1995) 7.63
Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis (2008) 6.53
Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A (2005) 6.39
Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis (2010) 3.86
The effect of deforestation on the human-biting rate of Anopheles darlingi, the primary vector of Falciparum malaria in the Peruvian Amazon. Am J Trop Med Hyg (2006) 3.72
Serology: a robust indicator of malaria transmission intensity? Trends Parasitol (2007) 3.63
DDT, global strategies, and a malaria control crisis in South America. Emerg Infect Dis (1997) 3.16
Control to elimination: implications for malaria research. Trends Parasitol (2008) 3.06
Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J (2008) 3.02
Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One (2009) 2.94
Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Malar J (2005) 2.77
Sub-microscopic malaria cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication for malaria elimination. Malar J (2010) 2.75
The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa. Malar J (2009) 2.66
Alternative polymerase chain reaction method to identify Plasmodium species in human blood samples: the semi-nested multiplex malaria PCR (SnM-PCR). Trans R Soc Trop Med Hyg (2002) 2.62
Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis (2010) 2.59
High-throughput pooling and real-time PCR-based strategy for malaria detection. J Clin Microbiol (2009) 2.52
Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J (2010) 2.47
Malaria reemergence in the Peruvian Amazon region. Emerg Infect Dis (1999) 2.46
Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea. PLoS One (2011) 2.18
PCR as a confirmatory technique for laboratory diagnosis of malaria. J Clin Microbiol (2006) 1.98
Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli. Clin Diagn Lab Immunol (1995) 1.92
A new challenge for malaria control in Brazil: asymptomatic Plasmodium infection--a review. Mem Inst Oswaldo Cruz (2006) 1.90
Prospects for malaria eradication in sub-Saharan Africa. PLoS One (2008) 1.82
Amazonian malaria: asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies. Acta Trop (2011) 1.78
The El Niño southern oscillation and malaria epidemics in South America. Int J Biometeorol (2002) 1.74
Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central Africa. J Infect Dis (2009) 1.65
Socio-demographics and the development of malaria elimination strategies in the low transmission setting. Acta Trop (2011) 1.43
Relationship between entomological inoculation rate, Plasmodium falciparum prevalence rate, and incidence of malaria attack in rural Gabon. Acta Trop (2003) 1.31
Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia. Malar J (2012) 1.27
Environmental risk factors for clinical malaria: a case-control study in the Grau region of Peru. Trans R Soc Trop Med Hyg (2002) 1.23
Environmental factors as determinants of malaria risk. A descriptive study on the northern coast of Peru. Trop Med Int Health (2002) 1.22
Seroepidemiological studies of malaria in pregnant women and newborns from coastal El Salvador. Am J Trop Med Hyg (1980) 1.20
Making sense of long-term changes in malaria. Lancet (2008) 1.15
Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru. Am J Trop Med Hyg (2003) 1.14
Conservation and heterogeneity of the glutamate-rich protein (GLURP) among field isolates and laboratory lines of Plasmodium falciparum. Mol Biochem Parasitol (2000) 1.14
True versus apparent malaria infection prevalence: the contribution of a Bayesian approach. PLoS One (2011) 1.12
Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru. Am J Trop Med Hyg (2003) 1.10
Asymptomatic Plasmodium parasitemia and the ecology of malaria transmission. Am J Trop Med Hyg (2002) 1.09
[Long-lasting insecticide - treated bednet ownership, retention and usage one year after their distribution in Loreto, Peru]. Rev Peru Med Exp Salud Publica (2011) 0.98
Immunophoretic rapid diagnostic tests as a source of immunoglobulins for estimating malaria sero-prevalence and transmission intensity. Malar J (2009) 0.98
A retrospective analysis of the change in anti-malarial treatment policy: Peru. Malar J (2009) 0.97
Serological detection of Plasmodium vivax malaria using recombinant proteins corresponding to the 19-kDa C-terminal region of the merozoite surface protein-1. Malar J (2003) 0.97
Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium. Mem Inst Oswaldo Cruz (2007) 0.96
Rapid assessment of the performance of malaria control strategies implemented by countries in the Amazon subregion using adequacy criteria: case study. Malar J (2011) 0.80
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Hyg (2006) 5.91
In vivo parasitological measures of artemisinin susceptibility. J Infect Dis (2010) 4.25
History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev (2004) 3.40
Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J (2008) 3.02
Decomposing socioeconomic inequality in infant mortality in Iran. Int J Epidemiol (2006) 2.95
Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One (2009) 2.94
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst (2013) 2.93
On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis (2010) 2.91
Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. BMJ (2009) 2.84
Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. Trans R Soc Trop Med Hyg (2006) 2.79
Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat (2010) 2.75
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. J Clin Oncol (2013) 2.71
Epidemiology of forest malaria in central Vietnam: a large scale cross-sectional survey. Malar J (2005) 2.67
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature (2012) 2.66
Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis (2007) 2.66
Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis (2010) 2.59
Malaria and urbanization in sub-Saharan Africa. Malar J (2005) 2.56
Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med (2007) 2.54
Four Artemisinin-Based Treatments in African Pregnant Women with Malaria. N Engl J Med (2016) 2.50
Pharmacovigilance of antimalarial treatment in Africa: is it possible? Malar J (2006) 2.48
Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy? Lancet Infect Dis (2009) 2.46
Reductions in malaria and anaemia case and death burden at hospitals following scale-up of malaria control in Zanzibar, 1999-2008. Malar J (2011) 2.45
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS One (2009) 2.43
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39
Forest malaria in Vietnam: a challenge for control. Am J Trop Med Hyg (2004) 2.34
Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J Infect Dis (2007) 2.33
Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLoS Pathog (2010) 2.30
Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey. PLoS One (2011) 2.24
Socioeconomic inequality in malnutrition in developing countries. Bull World Health Organ (2008) 2.18
A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax. Blood (2011) 2.17
Human Plasmodium knowlesi infections in young children in central Vietnam. Malar J (2009) 2.13
Multiple insecticide resistance: an impediment to insecticide-based malaria vector control program. PLoS One (2011) 2.07
Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis. PLoS One (2009) 2.05
Socioeconomic inequality in infant mortality in Iran and across its provinces. Bull World Health Organ (2005) 2.03
Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. Infect Immun (2007) 2.01
Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. Adv Parasitol (2009) 1.96
Spatial targeted vector control in the highlands of Burundi and its impact on malaria transmission. Malar J (2007) 1.93
Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family. Infect Immun (2002) 1.93
Influenza-like illness sentinel surveillance in Peru. PLoS One (2009) 1.90
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res (2010) 1.90
Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet (2002) 1.88
Spatial targeted vector control is able to reduce malaria prevalence in the highlands of Burundi. Am J Trop Med Hyg (2008) 1.88
The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg (2004) 1.86
Analysis of the OspE determinants involved in binding of factor H and OspE-targeting antibodies elicited during Borrelia burgdorferi infection in mice. Infect Immun (2003) 1.86
Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing. Malar J (2008) 1.85
Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malar J (2009) 1.80
Malaria in central Vietnam: analysis of risk factors by multivariate analysis and classification tree models. Malar J (2008) 1.79
Amazonian malaria: asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies. Acta Trop (2011) 1.78
Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Malar J (2010) 1.77
Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Malar J (2008) 1.76
Culture-independent species typing of neotropical Leishmania for clinical validation of a PCR-based assay targeting heat shock protein 70 genes. J Clin Microbiol (2004) 1.75
Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genes. Proc Natl Acad Sci U S A (2010) 1.74
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J (2011) 1.73
A decline in the incidence of invasive non-typhoidal Salmonella infection in The Gambia temporally associated with a decline in malaria infection. PLoS One (2010) 1.72
Prioritizing emerging zoonoses in the Netherlands. PLoS One (2010) 1.72
Vector control in a malaria epidemic occurring within a complex emergency situation in Burundi: a case study. Malar J (2007) 1.66
Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements. PLoS One (2008) 1.65
A significant increase in kdr in Anopheles gambiae is associated with an intensive vector control intervention in Burundi highlands. Trop Med Int Health (2008) 1.63
Evidence-based semiquantitative methodology for prioritization of foodborne zoonoses. Foodborne Pathog Dis (2009) 1.62
Malaria and water resource development: the case of Gilgel-Gibe hydroelectric dam in Ethiopia. Malar J (2009) 1.60
Long-Lasting Insecticidal Hammocks for controlling forest malaria: a community-based trial in a rural area of central Vietnam. PLoS One (2009) 1.58
Malnutrition and the disproportional burden on the poor: the case of Ghana. Int J Equity Health (2007) 1.58
Malaria in pregnancy: what can the social sciences contribute? PLoS Med (2007) 1.56
Can amodiaquine be used safely during pregnancy? Lancet Infect Dis (2004) 1.55
Weighing risk factors associated with bee colony collapse disorder by classification and regression tree analysis. J Econ Entomol (2010) 1.53
Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Lancet Infect Dis (2012) 1.53
Long-lasting insecticidal nets fail at household level to reduce abundance of sandfly vector Phlebotomus argentipes in treated houses in Bihar (India). Trop Med Int Health (2008) 1.51
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet (2011) 1.51
Rapid decrease of malaria morbidity following the introduction of community-based monitoring in a rural area of central Vietnam. Malar J (2009) 1.51
Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. Malar J (2006) 1.50
Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design. J Infect Dis (2004) 1.48
Multilocus genotyping reveals high heterogeneity and strong local population structure of the Plasmodium vivax population in the Peruvian Amazon. Malar J (2010) 1.43
Socio-demographics and the development of malaria elimination strategies in the low transmission setting. Acta Trop (2011) 1.43
Multiple hybrid genotypes of Leishmania (viannia) in a focus of mucocutaneous Leishmaniasis. Am J Trop Med Hyg (2007) 1.41
Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola. Trans R Soc Trop Med Hyg (2005) 1.40
Case management of severe malaria--a forgotten practice: experiences from health facilities in Uganda. PLoS One (2011) 1.39
Intensity of malaria transmission and the spread of Plasmodium falciparum resistant malaria: a review of epidemiologic field evidence. Am J Trop Med Hyg (2007) 1.39
An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso. Malar J (2012) 1.39
High complexity of Plasmodium vivax infections in symptomatic patients from a rural community in central Vietnam detected by microsatellite genotyping. Am J Trop Med Hyg (2010) 1.38
Ranking malaria risk factors to guide malaria control efforts in African highlands. PLoS One (2009) 1.38
Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children. Malar J (2011) 1.38
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res (2012) 1.38